Lacosamide, Serum
Ordering Recommendation
Optimize drug therapy and monitor patient adherence.
New York DOH Approval Status
Specimen Required
Timing of specimen collection: Predose (trough) draw at steady-state concentration.
Plain red.
Separate serum from cells within 2 hours of collection. Transfer 1 mL serum to an ARUP standard transport tube. (Min: 0.5 mL)
Refrigerated: Also acceptable: Room temperature or frozen.
Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution).
Ambient: 48 hours; Refrigerated: 1 week; Frozen: 1 month
3 freeze/thaw cycles
Methodology
Quantitative Enzyme Immunoassay (EIA)
Performed
Sun-Sat
Reported
1-2 days
Reference Interval
Test Number |
Components |
Reference Interval |
||||
---|---|---|---|---|---|---|
Lacosamide, Serum |
|
Interpretive Data
Lacosamide is an anticonvulsant drug indicated for adjunctive therapy for partial-onset seizures. The therapeutic range is based on serum, predose (trough) draw collection at steady-state concentration. Adverse effects may include dizziness, fatigue, nausea, vomiting, blurred vision, and tremor.
FDA
Note
Hotline History
Hotline History
CPT Codes
80235
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
3017895 | Lacosamide, Serum | 59297-2 |
Aliases
- Lacosamide blood level
- Vimpat
- vimpat blood level